Citations

Clear

9383 citation(s) found for "Thomas, PS".

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
Geyer, Holly L. , Scherber, Robyn M. , Dueck, Amylou C. , Kiladjian, Jean‐Jacques , Xiao, Zhijian , Slot, Stefanie , Zweegman, Sonja , Sackmann, Federico, Fuentes, Ana Kerguelen, Hernández‐Maraver, Dolores , Döhner, Konstanze , Harrison, Claire , Radia, Deepti , Muxí, Pablo , Besses, Carlos , Cervantes, Francisco , Johansson, Peter , Andréasson, Björn , Rambaldi, Alessandro , Barbui, Tiziano , Passamonti, Francesco , Samuelsson, Jan , Birgegård, Gunnar , Zweegman, Sonja , Vannucchi, Alessandro M. , Mesa, Ruben A. , Dueck, A. C. , Kiladjian, Jean-Jacques , Rambaldi, Alessandro , Passamonti, Francesco

Mayo Clinic

Blood | February 20, 2014 | Volume: 123 | Issue: 24 | Pages: 3803-3810

10.1182/blood-2013-09-527903 | PMID 24553173 Get It

Key Points Distinct clusters exist within polycythemia vera, essential thrombocythemia, and myelofibrosis. Clusters are not direct surrogates for current prognostic scores.
Retinal Microvascular Abnormalities Predict Progression of Brain Microvascular Disease
Hanff, Thomas C. , Sharrett, A. Richey, Shibata, Dean , Mosley, Thomas H. , Knopman, David S. , Klein, Ronald , Gottesman, Rebecca F.

Mayo Clinic

Stroke | February 19, 2014 | Volume: 45 | Issue: 4 | Pages: 1012-1017

10.1161/strokeaha.113.004166 | PMID 24549866 Get It

Background and Purpose— Brain microvascular disease leads to leukoaraiosis and lacunar infarcts and contributes to risk of stroke and cognitive decline. Given a shared pathophysiology, retinal microvascular signs are expected to predict brain microvascular disease progression. We investigated if either leukoaraiosis volume progression measured continuously or combined with incident lacunar infarcts would better demonstrate expected associations with retinal disease than has previously been shown. Methods— Eight hundred thirty participants in the Atherosclerosis Risk in Communities (ARIC) study aged ≥55 years and without previous stroke received an initial brain magnetic resonance imaging, retinal photography, and, 10 years later, a follow up magnetic resonance imaging. We evaluated retinal vascular sign phenotypes as predictors of (1) leukoaraiosis volume increase, and (2) a new score combining leukoaraiosis volume change and incident lacunar infarcts. Hypertension and diabetes mellitus were evaluated as confounders and effect modifiers. Results— Individuals with any retinopathy (3.34 cm 3 ; 95% confidence interval [CI], 0.74–5.96) or with arteriovenous nicking (2.61 cm 3 ; 95% CI, 0.80–4.42) each had greater progression of leukoaraiosis compared with those without these conditions. Any retinopathy (odds ratio [OR], 3.18; 95% CI, 1.71–5.89) or its components—microaneurysms (OR, 3.06; 95% CI, 1.33–7.07) and retinal hemorrhage (OR, 3.02; 95% CI, 1.27–7.20)—as well as arteriovenous nicking (OR, 1.93; 95%, CI 1.24–3.02) and focal arteriolar narrowing (OR, 1.76; 95% CI, 1.19–2.59), were associated with a higher quartile of a novel brain microvascular disease score combining leukoaraiosis progression with incident subclinical lacunes. Conclusions— A novel scoring method revealed associations of retinal signs with leukoaraiosis progression and brain microvascular disease, which have not been shown before.
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean‐Philippe, Haïoun, Corinne , Thompson, Carrie A. , Delarue, Richard, Micallef, Ivana N. , Peyrade, Frédéric, Macon, William R. , Molina, Thierry Jo , Ketterer, Nicolas , Syrbu, Sergei , Fitoussi, Olivier , Kurtin, Paul J. , Allmer, Cristine, Nicolas‐Virelizier, Emmanuelle , Link, Brian K. , Salles, Gilles , Tilly, Hervé , Cerhan, James R. , Jaïs, Jean‐Philippe , Witzig, Thomas E. , Slager, Susan L. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K , Salles, Gilles A , Syrbu, Sergei

Mayo Clinic

Journal of Clinical Oncology | February 19, 2014 | Volume: 32 | Issue: 10 | Pages: 1066-1073

10.1200/jco.2013.51.5866 | PMID 24550425 Get It

Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using a time-to-event approach with relapse, re-treatment, and death commonly used as the events. We evaluated the timing and type of events in newly diagnosed DLBCL and compared patient outcome with reference population data. Patients and Methods Patients with newly diagnosed DLBCL treated with immunochemotherapy were prospectively enrolled onto the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource (MER) and the North Central Cancer Treatment Group NCCTG-N0489 clinical trial from 2002 to 2009. Patient outcomes were evaluated at diagnosis and in the subsets of patients achieving event-free status at 12 months (EFS12) and 24 months (EFS24) from diagnosis. Overall survival was compared with age- and sex-matched population data. Results were replicated in an external validation cohort from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Lymphome Non Hodgkinien 2003 (LNH2003) program and a registry based in Lyon, France. Results In all, 767 patients with newly diagnosed DLBCL who had a median age of 63 years were enrolled onto the MER and NCCTG studies. At a median follow-up of 60 months (range, 8 to 116 months), 299 patients had an event and 210 patients had died. Patients achieving EFS24 had an overall survival equivalent to that of the age- and sex-matched general population (standardized mortality ratio [SMR], 1.18; P = .25). This result was confirmed in 820 patients from the GELA study and registry in Lyon (SMR, 1.09; P = .71). Simulation studies showed that EFS24 has comparable power to continuous EFS when evaluating clinical trials in DLBCL. Conclusion Patients with DLBCL who achieve EFS24 have a subsequent overall survival equivalent to that of the age- and sex-matched general population. EFS24 will be useful in patient counseling and should be considered as an end point for future studies of newly diagnosed DLBCL.
Reversible non‐ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single‐centre experience
Yataco, Maria, Difato, Thomas, Bargehr, Johannes , Rosser, Barry G., Patel, Tushar , Trejo-Gutiérrez, Jorge F. , Pungpapong, Surakit , Aranda‐Michel, Jaime, Yataco, Maria L, Taner, C. Burcin , Patel, Tushar , Pungpapong, Surakit

Mayo Clinic

Liver International | February 17, 2014 | Volume: 34 | Issue: 6 | Pages: No page available

10.1111/liv.12501 | PMID 24529030 Get It

AbstractBackground & AimsNon‐ischaemic cardiomyopathy (NIC) is an early complication of liver transplantation (LT). Our aims were to define the prevalence, associated clinical factors, and prognosis of this condition.MethodsA retrospective study was performed on patients undergoingLTat our institution from January 2005 to December 2012. Patients who developedNICwere identified. Data collected included demographic and clinical data.ResultsA total 1460 transplants were performed in this period and seventeen patients developedNIC. Pretransplant medianQTc interval was 459 (range, 405–530), and median E/A ratio was 1 (range, 0.71–1.67). Fourteen patients (82%) were severely malnourished and required nutritional support. Thirteen patients (76%) had renal insufficiency. Median time to onset was 2 days post‐transplant (range, 0–20). Echocardiograms showed global left ventricular hypokinesis and a decrease in ejection fraction (EF) from a median of 65% (range, 50–81) pretransplant to a median of 21% (range, 15–32). Median raw model for end‐stage liver disease (MELD) score was 29 in patients withNICvs. 18 in patients without cardiomyopathy (P = 0.01). There was no significant difference between recipients withNICvs. recipients without cardiomyopathy regarding donor age, donor risk index, and cold and warm ischaemia time. Recovery of cardiac function occurred in 16 patients, with a medianEFof 44% (range, 25–65%) at the time of discharge. The last echocardiogram available showed a medianEFof 59% (range, 49–73%). One‐year survival of NIC patients was 94.1%.ConclusionNon‐ischaemic cardiomyopathy is a rare complication afterLT. Patients withNICare critically ill, with highMELDscore, and severe malnutrition.
Essential tremor is not associated with cerebellar Purkinje cell loss
Symanski, Claire, Shill, Holly A. , Dugger, Brittany N. , Hentz, Joseph G. , Jacobson, Sandra A. , Driver‐Dunckley, Erika, Beach, Thomas G. , Symanski, Claire A., Adler, Charles H. , Driver‐Dunckley, Erika , Dugger, Brittany N

Mayo Clinic

Movement Disorders | February 17, 2014 | Volume: 29 | Issue: 4 | Pages: 496-500

10.1002/mds.25845 | PMID 24532134 Get It

ABSTRACT There has been controversy as to whether there is an underlying neurodegenerative process of the cerebellum in essential tremor (ET). The aim of this study was to examine whether ET is associated with Purkinje cell (PC) loss. Prospectively categorized ET and control subjects who were longitudinally examined in the Arizona Study for Aging and Neurodegenerative Disorders and came to autopsy between 1998 and 2013 underwent standardized neuropathological assessment of the brain. PC linear density of the cerebellar hemisphere was calculated in a blinded manner. There were 56 ET cases and 62 age‐matched controls free of dementia and other neurodegenerative disorders included in the study. Mean PC linear density was 3.80 ± 0.81 cells per mm for tremor cases and 3.82 ± 0.91 cells per mm for controls ( Δ 0.02; 95% confidence interval [CI]: −0.30‐0.34). PC counts were not associated with tremor duration (r = 0.06; 95% CI: −0.21‐0.32). These data demonstrate that ET is not associated with cerebellar PC loss. © 2014 International Parkinson and Movement Disorder Society
Interatrial pressure gradients during simulated obstructive sleep apnea: A catheter‐based study
Konečný, Tomáš , Khanna, Amber , Jama, Abdi A., Zawadowski, George, Orban, Marek , Pressman, Gregg S. , Bukartyk, Jan , Kára, Tomáš, Cetta, Frank , Reeder, Guy S., Novák, Jan , Borlaug, Barry A. , Somers, Virend K. , Khanna, Amber D

Mayo Clinic

Catheterization and Cardiovascular Interventions | February 13, 2014 | Volume: 84 | Issue: 7 | Pages: 1138-1145

10.1002/ccd.25433 | PMID 24677689 Get It

ObjectivesWe set to measure the interatrial pressure gradient during simulated obstructive sleep apnea (OSA).BackgroundOSA occurs when a sleeping patient attempts to inhale against an obstructed airway. How this event affects the interatrial pressure gradient has not been defined. We hypothesized that simulated OSA in a conscious subject (Mueller maneuver [MM], inspiration against obstruction) would promote increased right‐to‐left pressure gradient, and then the substrate for right‐to‐left atrial shunting.MethodsSelected patients underwent simultaneous measurement of airway and atrial pressures (both left and right atrium [LA, RA]) using high‐fidelity micromanometry at rest, during MM, and during VM, during right heart catheterization.ResultsTen patients (age 55 ± 11 years, two women) were successfully studied. During the onset of MM, RA pressure transiently but consistently exceeded LA pressure in response to the steep decline in intrathoracic pressure (maximum RA‐LA pressure gradient increased from 0.1 ± 1.4 mm Hg at baseline to 7.0 ± 4.3 mm Hg during MM, P < 0.001). The maximum right‐to‐left atrial pressure gradient during Mueller maneuver was higher than that achieved during the Valsalva maneuver release (P < 0.007).ConclusionsThe onset of MM increased right‐to‐left pressure gradient across the atrial septum, likely as a result of greater blood return to the RA from extrathoracic veins. The RA‐LA pressure gradient achieved during MM was greater than that observed during VM. These findings delineate the hemodynamic substrate for right to left shunting during OSA. © 2014 Wiley Periodicals, Inc.
Increased prosthetic valve gradients: Abnormal prosthetic function or pressure recovery?
Eleid, Mackram F. , Thomas, James D. , Nishimura, Rick A.

Mayo Clinic

Catheterization and Cardiovascular Interventions | February 12, 2014 | Volume: 84 | Issue: 6 | Pages: 908-911

10.1002/ccd.25432 | PMID 24677668 Get It

The non‐invasive evaluation of prosthetic valve function is challenging. The effects of flow rate, valvular geometry, leaflet motion, and pressure recovery all impact the Doppler assessment of prosthetic performance. Differentiating prosthesis obstruction from pressure recovery in patients who are found to have high Doppler velocities across an aortic valve prosthesis is critical in order to direct appropriate management. In this manuscript, we present two cases of patients with aortic valve prosthesis with high Doppler velocities and review the pathophysiology and evaluation of prosthesis function. © 2014 Wiley Periodicals, Inc.
Liver-Specific GH Receptor Gene-Disrupted (LiGHRKO) Mice Have Decreased Endocrine IGF-I, Increased Local IGF-I, and Altered Body Size, Body Composition, and Adipokine Profiles
Berryman, Darlene E. , Funk, Kevin, Jara, Adam , Kelder, Bruce, Wang, Feiya , Zhi, Xu , Sun, Liou Y. , White, Thomas A. , LeBrasseur, Nathan K. , Pirtskhalava, Tamara, Tchkonia, Tamar , Jensen, Elizabeth , Kirkland, James L. , Miller, Richard A. , Kopchick, John J. , List, Edward O, List, Edward Owen , Stout, Michael B , Zhang, Wenjuan , Masternak, Michal M , Bartke, Andrzej , Tchkonia, T , LeBrasseur, Nathan K

Mayo Clinic

Endocrinology | February 11, 2014 | Volume: 155 | Issue: 5 | Pages: 1793-1805

10.1210/en.2013-2086 | PMID 24517230 Get It

GH is an important regulator of body growth and composition as well as numerous other metabolic processes. In particular, liver plays a key role in the GH/IGF-I axis, because the majority of circulating “endocrine” IGF-I results from GH-stimulated liver IGF-I production. To develop a better understanding of the role of liver in the overall function of GH, we generated a strain of mice with liver-specific GH receptor (GHR) gene knockout (LiGHRKO mice). LiGHRKO mice had a 90% decrease in circulating IGF-I levels, a 300% increase in circulating GH, and significant changes in IGF binding protein (IGFBP)-1, IGFBP-2, IGFBP-3, IGFBP-5, and IGFBP-7. LiGHRKO mice were smaller than controls, with body length and body weight being significantly decreased in both sexes. Analysis of body composition over time revealed a pattern similar to those found in GH transgenic mice; that is, LiGHRKO mice had a higher percentage of body fat at early ages followed by lower percentage of body fat in adulthood. Local IGF-I mRNA levels were significantly increased in skeletal muscle and select adipose tissue depots. Grip strength was increased in LiGHRKO mice. Finally, circulating levels of leptin, resistin, and adiponectin were increased in LiGHRKO mice. In conclusion, LiGHRKO mice are smaller despite increased local mRNA expression of IGF-I in several tissues, suggesting that liver-derived IGF-I is indeed important for normal body growth. Furthermore, our data suggest that novel GH-dependent cross talk between liver and adipose is important for regulation of adipokines in vivo.
Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab
Smeltzer, Jacob P., Howard, Matthew T., Gonsalves, Wilson I. , Witzig, Thomas E.

Mayo Clinic

Case Reports in Hematology | February 10, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-4

10.1155/2014/641483 | PMID 24660077 Get It

Epstein-Barr virus (EBV) is a ubiquitous virus that commonly affects children and adolescents. In addition to causing a viral illness, it is also associated with various malignancies in particular B cell lymphomas and lymphoproliferative disorders. Differentiating between the two processes can be a diagnostic challenge. Here, we present a case of an atypical EBV infection in an elderly patient with severe systemic symptoms, multiorgan involvement, lymphadenopathy, and negative EBV serology. Excisional lymph node biopsy demonstrated features of a lymphoproliferative process involving EBV. Despite supportive care, she experienced continued clinical deterioration and was successfully treated with rituximab. This case illustrates the diagnostic challenges of these cases particularly in the elderly who may have age related immunosenescence, the utility of EBV PCR testing, and the clinical efficacy of rituximab in clearing the infected cells.
Oncologic Safety of the Submental Flap for Reconstruction in Oral Cavity Malignancies
Howard, Brittany E. , Nagel, Thomas H. , Donald, Carrlene B., Hinni, Michael L., Hayden, Richard E.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | February 6, 2014 | Volume: 150 | Issue: 4 | Pages: 558-562

10.1177/0194599814520687 | PMID 24503306 Get It

ObjectivesTo evaluate the oncologic safety of the submental flap regarding potential transposition of involved nodes to the reconstruction site and recognize the submental flap as an excellent option for oral cavity reconstruction.Study DesignCase series with chart review.SettingTertiary academic referral center.Subjects and MethodsAll patients undergoing reconstruction with submental flaps following the resection of primary and recurrent malignancies of the oral cavity between 2002 and 2012 were reviewed. Analysis included tumor location, staging, reconstructive details, postoperative course, and outcomes.ResultsFifty patients were identified having undergone submental flap reconstruction of defects following resection for oral cavity malignancies. No patient had identifiable clinical or radiographic level I nodal involvement preoperatively. Patients’ ages ranged from 35 to 88 years (mean, 70 years). American Joint Committee on Cancer staging of patients included stage II (n = 16, 32%), stage III (n = 10, 20%), and stage IVa disease (n = 28, 48%). All patients underwent a level 1A and 1B dissection with removal of the nodal basin and submandibular gland. The prevalence of occult lymph node metastasis involving level 1 was 10%. On follow‐up, there were no local recurrences associated with submental flap transposition to the oral cavity. One patient with multifocal oral disease had a tongue recurrence geographically separate from the submental flap reconstruction. There was 100% flap survival.ConclusionsThe submental flap provides a rapid and reliable option for oral cavity defect reconstruction. With appropriate management of the level 1 nodal compartment, oncologic outcomes are not compromised.